Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

By Proactive Investors / December 28, 2023 / www.youtube.com / Article Link


Tonix Pharmaceuticals CEO Dr. Seth Lederman recently recently shared groundbreaking news during an interview with Steve ...

Recent News

Gold stocks decline on flat metal and mixed equities
October 07, 2024 / www.canadianminingreport.com

Copper price expected to range from flat to slight gain in 2025
October 07, 2024 / www.canadianminingreport.com

China's gold holdings to central bank reserves still low
September 30, 2024 / www.canadianminingreport.com

China has broad effect on gold market
September 30, 2024 / www.canadianminingreport.com

Gold stocks mixed after previous week's huge gains
September 23, 2024 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok